|
|
 |
|
Viewing report
|
|
|
|
Crohn’s Disease – Drug Pipeline Analysis and Market Forecasts to 2015
GlobalData, Dec 2009, Pages: 43
“Crohn’s Disease – Drug Pipeline Analysis and Market Forecasts to 2015” is an essential source of information and analysis on the global Crohn’s disease market. The report identifies the key trends shaping and driving the global Crohn’s disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global Crohn’s disease sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by a team of industry experts.
Scope
The scope of the report includes:
- Annualized global Crohn’s disease market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
- Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action includes TNF-alpha inhibitor, IL-12 and 23 inhibitor, IL-6 inhibitor, IL-17 inhibitor, chemokine receptor inhibitor, Co stimulation modulator, Anti CD3 molecules, Anti MAP agent, Cell adhesion molecule inhibitor, Oral adsorbents, Other immunosupressors, Stem cell therapy.
- Analysis of the current and future market competition in the global Crohn’s disease market. Key market players covered are Chemocentryx Inc., Bristol-Myers Squibb, Abbott laboratories and Johnson & Johnson.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with Crohn’s disease.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Crohn’s disease market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global Crohn’s disease market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Crohn’s disease market landscape? – Identify, understand and capitalize.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success
Gastrointestinal Disorder Therapeutics Market to 2017 - Crohn's Disease and Irritable Bowel Syndrome Markets Show Strongest Growth
Autoimmune Market Forecast to 2014
Strategic Overview of the Autoimmune Biologics Market
The Future of Autoimmune Diseases Therapeutics – Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deal Analysis
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments
Pipeline Insight: Inflammatory Bowel Disease - Varied drug targets to broaden future therapy options
Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
Crohn's Disease (CD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Special Report: The Autoimmune Biologics Pipeline-A Competitive Review
|
|
|
|
